Horizon chief exec Walbert to head up US biotech trade body
pharmafile | December 18, 2015 | Appointment | Manufacturing and Production, Research and Development, Sales and Marketing | Illinois Biotechnology Industry Organisation, Timothy Walbert, iBio, illinois
Timothy Walbert, the chairman, president and chief executive of Horizon Pharma, has been elected as chairman of the board of directors at iBIO, the Illinois Biotechnology Industy Organisation.
He succeeds Takeda’s Andrew Hull Pharmaceutical, who served as chairman for the past two years and will continue to serve on the board and the executive committee.
iBIO, founded in 2002, represents over 100 biotechnology companies in Illinois. Its mission is to make Illinois and the surrounding Midwest US region “one of the world’s top life sciences centres: a great place to do business and a great place to grow technology ventures.”
Walbert joined Horizon Pharma in 2008 and under his leadership, Horizon has experienced unprecedented growth and success. It was named the fastest-growing company in Illinois and ranked first in Chicago in revenue growth across all business sectors by Crain’s Chicago Business in 2014. Walbert has built Horizon into a global company of more than 800 employees with offices in four countries.
Walbert says: “I am honoured to be elected chairman and look forward to working with iBIO’s leadership to continue to make Illinois a globally recognized life sciences centre. Our community has all of the elements needed to cultivate a sustainable biotech and science ecosystem, and it’s exciting to be a part of the continued growth and innovation.”
“Tim’s commitment to establishing Chicago and Illinois as a thriving biopharmaceutical and biotechnology hub, along with his business acumen and current involvement with the national BIO board, makes him an ideal person for this role,” says iBIO president and chief executive, Warren Ribley. “Horizon Pharma’s growth trajectory is a compelling success story for our community and having Tim’s calibre of leadership as our chairman will be an invaluable asset to our organisation and members.”
Related Content
Takeda set to move from Deerfield Illinois, 1000 jobs affected
Japanese multinational Takeda is set to shut down its US headquarters in Deerfield, Illinois following …
Hospira closing US manufacturing plant
US injectable drugs specialist Hospira is to close its Clayton plant in North Carolina affecting …
GE and iBio expand plant production alliance
GE Healthcare and iBio have forged an alliance to commercialise plant-based technologies for the manufacture …
